Cowen reiterated a Market Perform rating on Regeneron Pharma (NASDAQ: REGN), and raised the price target to $575.00 (from $550.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Leerink Partners Reiterated Outperform Following Regeneron's (REGN) 3Q Beat November 5, 2015 8:07 AM Regeneron (REGN) Tops Q3 EPS by 33cNovember 4, 2015 6:31 AM Regeneron Reports Third Quarter 2015 Financial and Operating ResultsNovember 4, 2015 6:30 AM Trading Radar 11/4: Facebook (FB), Qualcomm (QCOM), MetLife (MET), Time Warner (TWX), Michael Kors (KORS) ReportNovember 3, 2015 2:45 PM